Vitamin market: Key pricing and supply trends
The global vitamin market is experiencing a mix of stability and price fluctuations, influenced by supply chain dynamics, currency exchange rates, and import duties. While Vitamin E prices are stabilizing amid planned plant maintenance, Vitamin A continues to weaken with buyers remaining cautious. Vitamin D3 remains elevated despite slight declines, and B-complex vitamins show mixed trends depending on the region. With most Q2 contracts already secured, the market is in a holding pattern as buyers assess future price movements.
In partnership with Feed Additive Prices
Vitamin E 50%
Prices ex-China have started to stabilise, as suppliers have a strong desire for stable/higher prices, and several plant maintenance periods have been announced. The overall vitamin E market was stable to weak until recently, but that is still the case in Europe. The USA is showing some price increases as higher import duties start to be priced in. Q2 is mostly contracted.
Vitamin A 1000
The market continues to show signs of weakness, with prices declining further across most regions last week, while BASF has indicated plans to resume production by April 2025. Many buyers are currently taking a cautious approach, purchasing only as needed, and it is noteworthy that the second quarter is already largely contracted.
Vitamin D3 500
Despite ongoing challenges with low stock levels and tight availability, there has been a slight decline in market prices, although they remain elevated. A significant portion of Q2 has already been contracted, as buyers anticipated little in terms of immediate price relief. For Q3, buyers have become more conservative and wait.
Vitamin B2 80%
The vitamin B2 market remains steady, showing no significant changes compared to previous weeks, with consistent pricing and a favourable outlook on supply availability. Looking ahead, no major fluctuations are expected in the near future. Most contracts for the second quarter are already secured.
D-Calpan
The vitamin B5 market remains largely stable across most regions, with Europe experiencing a slight decrease in prices attributed to a more favourable exchange rate of the Euro against the US dollar. Prices in USD have shown a modest increase as additional import duties begin to take effect. A significant portion of contracts for the second quarter has already been secured.
Vitamin B3
Despite the weaker market sentiment observed over the past few weeks being largely factored in, the overall mood remains somewhat stable to weak. In Europe, the recent strength of the EUR-USD has contributed to downward price trends, while in the USA, market stability is maintained as price drops are mitigated by increased import duties. The recent incident at a vitamin B3 production facility has had no significant impact on the prevailing bearish trend. While a substantial portion of Q2 has already been contracted, there are still outstanding volumes yet to be secured.
Biotin
The vitamin B5 market remains largely stable across most regions, with Europe experiencing a slight decrease in prices attributed to a more favourable exchange rate of the Euro against the US dollar. Prices in USD have shown a modest increase as additional import duties begin to take effect. A significant portion of contracts for the second quarter has already been secured.
Vitamin C 35% mono
Market trends indicate a decline in vitamin C prices across several regions, although suppliers are eager to raise or stabilise their prices. In the United States, this decline is less seen due to the implementation of import duties, whereas other regions, particularly Europe, are experiencing stable to weaker prices for vitamin C mono. With a significant portion of the second quarter already contracted, the market is adopting a wait-and-see approach regarding future business.
